About Emily

Emily has more than 20 years of experience representing life sciences companies in a broad range of complex commercial and business development matters. Before joining Cooley, she was vice president at Amgen, an American multinational biopharmaceutical company in Thousand Oaks, California, where she focused on law and compliance.

View full bio

Admissions and credentials

California

New York

Experience

Enlaza Therapeutics Announces Strategic Collaboration With Vertex Pharmaceuticals

Enlaza Therapeutics Announces Strategic Collaboration With Vertex Pharmaceuticals

September 2, 2025

Cooley advised Enlaza Therapeutics, the first covalent biologics platform company, on its multi-target drug discovery collaboration with Vertex Pharmaceuticals, to utilize Enlaza’s proprietary War-Lock technology platform to develop small format drug conjugates and T-cell engagers for certain autoimmune diseases and improved conditioning in sickle cell disease and beta thalassemia.

Read more

Related contacts

Charity Williams
Partner, San Diego
Emily Mason
Special Counsel, Santa Monica
Ken Rollins
Partner in Charge – San Diego, San Diego
Dylan Kornbluth
Associate, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Rachel Thorn
Of counsel, New York
Navya Dasari
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Matthew S. Scarano
Associate, San Diego
Max Levinbook
Associate, San Diego

Related Practices & Industries

Life Sciences Corporate Partnering and Licensing
Emerging Companies
Tax
Life Sciences and Healthcare Regulatory
Life Sciences
Debt Finance
Biotechnology

MannKind to Acquire scPharmaceuticals for up to $360 Million

MannKind to Acquire scPharmaceuticals for up to $360 Million

August 25, 2025

Cooley advised MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, on its definitive merger agreement to acquire scPharmaceuticals for up to $360 million

Read more

Related contacts

Barbara Borden
Senior Counsel, San Diego
Rowook Park
Partner, San Diego
Julia Kim
Special Counsel, New York
Mischi a Marca
Partner, San Francisco
Adam J. Longenbach
Partner, New York
Matthew S. Scarano
Associate, San Diego
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Todd Gluth
Partner, San Diego
Eric Greig
Partner, Washington, DC
Asa Henin
Partner, San Diego
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Stella Sarma
Partner, Brussels
Charity Williams
Partner, San Diego
Julia R. Brinton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Emily Mason
Special Counsel, Santa Monica
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
David Dalton
Associate, Santa Monica
Sharon Davidov
Associate, New York
Jameson Davis
Associate, Boston
Athina Gaki
Associate, Brussels
Tony P. Guan
Associate, Santa Monica
Josh Himmelstern
Associate, San Diego
Michelle Hunt
Associate
Wyatt Kernell
Associate, Colorado
Bomin Kim
Associate, New York
Allison Kutner
Associate, New York
Jacob R. Lahana
Associate, Santa Monica
Eileen Leman
Associate, Los Angeles
Walter Musgrave
Associate, San Diego
Joseph Perry
Associate, Reston
Allie Pilmer
Associate, San Diego
Breanna Qin
Associate, Palo Alto
Vittoria Rainone
Associate, San Diego
Bartholomäus Regenhardt
Associate, Brussels
Brittany K. Wightman
Associate, San Diego
Jennifer Fitzpatrick
Paralegal Specialist, Washington, DC

Related Practices & Industries

Mergers and Acquisitions
Life Sciences Corporate Partnering and Licensing
Debt Finance
Labor and Employment
Life Sciences and Healthcare Regulatory
Life Sciences
Compensation and Benefits
Capital Markets
Tax
Cyber/Data/Privacy
Antitrust and Competition
Healthcare

Vicebio to Be Acquired by Sanofi for $1.6 Billion

Vicebio to Be Acquired by Sanofi for $1.6 Billion

July 25, 2025

Cooley advised Medicxi and other venture capital investors in Sanofi’s $1.6 billion acquisition of Vicebio, a biopharmaceutical company that develops novel vaccines against life-threatening respiratory viral infections.

Read more

Related contacts

Russell Anderson
Partner, London
Simon Amies
Partner, London
Mark Jones
Associate, London
Charity Williams
Partner, San Diego
Emily Mason
Special Counsel, Santa Monica
Joe Sandys
Special Counsel, London
Jack Jones
Special Counsel, London
Eerik Kukebal
Associate, London

Related Practices & Industries

Mergers and Acquisitions
Emerging Companies
Venture Capital
Life Sciences
Life Sciences Corporate Partnering and Licensing
Healthcare
Biotechnology
Tax